Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Apomorphine

Brand: 
NICE TA: 
Indication: Parkinson's disease
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

Primary care prescribers are advised not to take on prescribing of apomorphine unless they have been adequately informed by letter of their responsibilities with regards monitoring, side effects and interactions and are happy to take on the prescribing responsibility. A copy of locally approved shared care guidelines should accompany this letter which outlines these responsibilities. Primary care prescribers should then tell secondary care of their intentions as soon as possible by letter so that arrangements can be made for the transfer of care.
Primary care prescribers should refer to their local CCG commissioning policies before entering in to a shared care arrangement for apomorphine.

Recommendation

LMMG recommendation: Amber1
Click here to find the definitions for the colour classifications

Reason for decision:  Shared care required

Supporting documents:

Apomorphine Shared Care Guidelines V1.0 - REFER TO LOCAL COMMISSIONING POLICY BEFORE USE (543.4 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber1

Red

Amber1

Red

Amber1

Amber1